Calabrese V, Cornelius C, Leso V, Trovato-Salinaro A, Ventimiglia B, Cavallaro M, Scuto M, Rizza S, Zanoli L, Neri S, Castellino P
Department of Chemistry, Faculty of Medicine, University of Catania, Catania, Italy.
Biochim Biophys Acta. 2012 May;1822(5):729-36. doi: 10.1016/j.bbadis.2011.12.003. Epub 2011 Dec 11.
Oxidative stress has been suggested to play a main role in the pathogenesis of type 2 diabetes mellitus and its complications. As a consequence of this increased oxidative status a cellular adaptive response occurs requiring functional chaperones, antioxidant production and protein degradation. This study was designed to evaluate systemic oxidative stress and cellular stress response in patients suffering from type 2 diabetes and in age-matched healthy subjects. Systemic oxidative stress has been evaluated by measuring plasma reduced and oxidized glutathione, as well as pentosidine, protein carbonyls lipid oxidation products 4-hydroxy-2-nonenal and F2-isoprostanes in plasma, and lymphocytes, whereas the lymphocyte levels of the heat shock proteins (HSP) HO-1, Hsp72, Sirtuin-1, Sirtuin-2 and thioredoxin reductase-1 (TrxR-1) have been measured to evaluate the systemic cellular stress response. Plasma GSH/GSSG showed a significant decrease in type 2 diabetes as compared to control group, associated with increased pentosidine, F2-isoprostanes, carbonyls and HNE levels. In addition, lymphocyte levels of HO-1, Hsp70, Trx and TrxR-1 (P<0.05 and P<0.01) in diabetic patients were higher than in normal subjects, while sirtuin-1 and sirtuin-2 protein was significantly decreased (p<0.05). In conclusion, patients affected by type 2 diabetes are under condition of systemic oxidative stress and, although the relevance of downregulation in sirtuin signal has to be fully understood, however induction of HSPs and thioredoxin protein system represent a maintained response in counteracting systemic pro-oxidant status. This article is part of a Special Issue entitled: Antioxidants and Antioxidant Treatment in Disease.
氧化应激被认为在2型糖尿病及其并发症的发病机制中起主要作用。由于这种氧化状态的增加,细胞会发生适应性反应,需要功能性伴侣蛋白、抗氧化剂的产生和蛋白质降解。本研究旨在评估2型糖尿病患者和年龄匹配的健康受试者的全身氧化应激和细胞应激反应。通过测量血浆中还原型和氧化型谷胱甘肽、戊糖苷、蛋白质羰基、脂质氧化产物4-羟基-2-壬烯醛和F2-异前列腺素以及淋巴细胞中的含量来评估全身氧化应激,而测量热休克蛋白(HSP)HO-1、Hsp72、沉默调节蛋白-1、沉默调节蛋白-2和硫氧还蛋白还原酶-1(TrxR-1)的淋巴细胞水平来评估全身细胞应激反应。与对照组相比,2型糖尿病患者血浆中谷胱甘肽/氧化型谷胱甘肽显著降低,同时戊糖苷、F2-异前列腺素、羰基和HNE水平升高。此外,糖尿病患者淋巴细胞中HO-1、Hsp70、硫氧还蛋白和TrxR-1的水平(P<0.05和P<0.01)高于正常受试者,而沉默调节蛋白-1和沉默调节蛋白-2的蛋白水平显著降低(P<0.05)。总之,2型糖尿病患者处于全身氧化应激状态,尽管沉默调节蛋白信号下调的相关性有待充分理解,但热休克蛋白和硫氧还蛋白系统的诱导代表了对全身促氧化状态的持续抵抗反应。本文是名为:疾病中的抗氧化剂和抗氧化治疗的特刊的一部分。